Tatara Therapeutics
Business Services · El Salvador · 1-10 Employees
View Company Info for Free
Overview
Headquarters
El SalvadorWebsite
www.tatararx.comRevenue
<$5 MillionIndustry
About Tatara Therapeutics
Tatara Therapeutics Org Chart
Is Tatara Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Tatara Therapeutics had a recent Job posting/layoffs
Product Launch: Get notified when Tatara Therapeutics launches new products
Congratulate Masked Content for being promoted to Masked Content at Tatara Therapeutics
Earning: See what the market has to say on Tatara Therapeutics recently announced quarterly report
Tatara Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Tatara Therapeutics has new funding data
Check out if Tatara Therapeutics is spiking on competitors!
Check if Tatara Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Tatara Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Tatara Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Tatara Therapeutics.
Tatara Therapeutics Tech Stack
A closer look at the technologies used by Tatara Therapeutics
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Tatara Therapeutics
Tatara Therapeutics specializes in iron-activated cancer therapeutics, utilizing a precision medicine chemistry platform that targets ferro-addiction in tumors. The company focuses on developing innovative drug conjugates, such as the novel ferrous-iron reactive (FIRE) conjugate of the topoisomerase-I inhibitor exatecan. Their research includes pre... Read More